Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
M Duijvestein, ACW Vos, H Roelofs, ME Wildenberg… - Gut, 2010 - gut.bmj.com
Background and aim Mesenchymal stromal cells (MSCs) are pluripotent cells that have
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone …
LL Kodach, RJ Jacobs, PW Voorneveld… - Gut, 2011 - gut.bmj.com
Background Promoter hypermethylation is an important and potentially reversible
mechanism of tumour suppressor gene silencing in cancer. Compounds that demethylate …
mechanism of tumour suppressor gene silencing in cancer. Compounds that demethylate …
[PDF][PDF] Chapter six Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
BB Wendrich, HW Verspaget… - Gut, 2010 - scholarlypublications …
Background and aim: Mesenchymal stromal cells (MSCs) are pluripotent cells that have
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …
immunosuppressive effects both in vitro and in experimental colitis. Promising results of …